1 – 10 of 12
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2025
- 
                        Mark
        Comorbidity and Mortality in Men and Women With Haemophilia in Three Nordic Countries–Comparisons to Matched Controls
    
    - Contribution to journal › Article
 
- 2023
- 
                        Mark
        High use of pain, depression, and anxiety drugs in hemophilia : more than 3000 people with hemophilia in an 11-year Nordic registry study
    
    - Contribution to journal › Article
 
- 
                        Mark
        Acquired Haemophilia A in four north European countries : survey of 181 patients
    
    - Contribution to journal › Article
 
- 
                        Mark
        No difference in quality of life between persons with severe haemophilia A and B
    
    - Contribution to journal › Article
 
- 2022
- 
                        Mark
        Pain, depression and anxiety in people with haemophilia from three Nordic countries : Cross-sectional survey data from the MIND study
    
    - Contribution to journal › Article
 
- 
                        Mark
        Factor IX antibodies and tolerance in hemophilia B in the Nordic countries - The impact of F9 variants and complications
    
    - Contribution to journal › Article
 
- 
                        Mark
        Quality of life in a large multinational haemophilia B cohort (The B-Natural study) – Unmet needs remain
    
    - Contribution to journal › Article
 
- 2021
- 
                        Mark
        Treatment outcomes in persons with severe haemophilia B in the Nordic region : The B-NORD study
    
    - Contribution to journal › Article
 
- 
                        Mark
        The B-Natural study—The outcome of immune tolerance induction therapy in patients with severe haemophilia B
    
    - Contribution to journal › Article
 
- 
                        Mark
        Natural history study of factor IX deficiency with focus on treatment and complications (B-Natural)
    
    - Contribution to journal › Article
 
